Figure 1.
Meta-Analysis indicating that anti-inflammatory strategies could benefit AD patients. (A) Flow diagram of the four studies included in the meta-analysis. (B) Risk of bias summary: review authors’ judgements about each risk of bias item for each included study. (C) Forest plot of pooled risk ratio (RR) for the anti-inflammation agent on the prevention or treatment of AD using the random effects model [37,40,41,42].
